Nivolumab Improves Survival in Advanced Gastric/GEJ Cancer
At the 2017 Gastrointestinal Cancers Symposium, researchers presented the exciting new study that treatment with nivolumab (Opdivo) reduces the risk of death... Read More
Older Patients with GI Cancers Don’t Always Receive Tx
New research shows older patients with unresected gastric cancer benefit from treatment, but many often do not receive cancer-specific therapy.
New insight into origin of stomach cancer
In a mouse model, researchers found that damage to acid-secreting cells alone doesn’t jump-start the transformation of healthy cells into precancerous cells.... Read More
Second-line Weekly Nab-paclitaxel Noninferior to Paclitaxel for Gastric Cancer
New research out of The Lancet Gastroenterology & Hepatology journal shows that weekly nab-paclitaxel was noninferior to weekly solvent-based paclitaxel as second-line... Read More
Chemotherapy and survival benefit in elderly patients with advanced gastric cancer
A new scoring system developed to help clinicians assess whether elderly patients would benefit from chemo was presented at ASCO’s 2017 Gastrointestinal... Read More
Faulty DNA error correction genes set stage for familial gastric cancer
UC Davis researchers have identified genetic variations that contribute to familial gastric cancer. Inherited mutations – which affect the PALB2, BRCA1 and... Read More
LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1
A PlosOne study finds the gene LGR5 is a stem cell marker associated with gastric cancer and other signature genes.
Aduro Biotech Announces Clinical Collaboration with Merck to Evaluate the Combination of Aduro’s CRS-207 with Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Gastric Cancer
Aduro Biotech, Inc. and Merck are launching a Phase 1 study of the combination of CRS-207, Aduro’s LADD (live, attenuated double-deleted) based... Read More
Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis
A new DovePress meta-analysis of nearly 3,000 patients shows that high proliferating cell nuclear antigen (PCNA) expression might be a promising therapeutic... Read More
Researchers uncover mechanism for cancer-killing properties of pepper plant
UT Southwestern Medical Center researchers have uncovered the chemical process behind the anti-cancer properties of the long pepper, a spicy Indian pepper plant,... Read More
